-
Structure-Based Discovery of NSP15 Inhibitors for SARS-CoV-2
2026-06-08
The referenced study introduces a structure-based virtual screening pipeline that identified thymopentin and oleuropein as potent inhibitors of the SARS-CoV-2 NSP15 endoribonuclease. These findings support the rational design of antivirals targeting viral immune evasion mechanisms, providing a valuable foundation for translational COVID-19 research.
-
NVP-BGJ398 Phosphate: Precision FGFR Inhibition in Cancer Mo
2026-06-08
NVP-BGJ398 phosphate is a potent, selective inhibitor of the FGFR signaling pathway with nanomolar activity against FGFR1-3, enabling targeted cancer research and translational studies in skeletal disorders. Its effectiveness in FGFR-driven endometrial cancer and SLC26A2-related chondrodysplasia is demonstrated in both in vitro and in vivo models. The compound’s specificity, solubility profile, and validated research applications make it a benchmark tool for dissecting FGFR signaling.
-
Synergistic Antibiotic Combinations in Neutropenic Lung Infe
2026-06-07
Li et al. (2020) demonstrate that colistin and gamithromycin act synergistically against Pasteurella multocida in a neutropenic murine lung infection model, enabling significant dose reductions for both agents. This study advances antimicrobial therapy design for resistant Gram-negative infections and offers a robust preclinical framework for translational research.
-
Diclofenac in Human Intestinal Organoids: A New Benchmark fo
2026-06-06
Explore how Diclofenac, a non-selective COX inhibitor, is revolutionizing inflammation and pharmacokinetic research using human intestinal organoids. This comprehensive review reveals advanced applications, technical guidance, and novel insights beyond conventional assay workflows.
-
Neuromedin S (rat): Technical Guidance for GPCR Assays
2026-06-05
Neuromedin S (rat) provides a chemically defined peptide agonist for precise activation of neuromedin U receptor signaling in rat-based GPCR/G protein research. This product enables controlled studies of pathways such as energy homeostasis regulation and stress response, but is not intended for diagnostic, therapeutic, or cross-species use.
-
N3-kethoxal: Advanced Probing of RNA–Protein Interactions in
2026-06-05
Discover how N3-kethoxal enables high-precision mapping of RNA–protein and DNA–protein interactions, revealing new insights into immunothrombosis. This article explores advanced applications and structural considerations for nucleic acid probing beyond conventional RNA structure mapping.
-
Diclofenac: Non-Selective COX Inhibitor in Intestinal Organo
2026-06-04
Diclofenac, a non-selective COX inhibitor, enables high-fidelity modeling of inflammation and pain signaling in human iPSC-derived intestinal organoids. This guide delivers practical protocols, troubleshooting insights, and comparative advantages for translational pharmacokinetic and anti-inflammatory research.
-
Ibrexafungerp and Caspofungin Against Resistant C. auris: St
2026-06-04
Wiederhold et al. provide rigorous evidence that ibrexafungerp, a novel oral triterpenoid, retains substantial in vitro and in vivo efficacy against fluconazole-resistant Candida auris, even with delayed therapy. Their direct comparison with caspofungin underscores the ongoing significance of β-(1,3)-D-glucan biosynthesis inhibition for tackling multidrug-resistant Candida infections.
-
LGK-974 (Porcupine Inhibitor): Precision for Wnt Pathway Stu
2026-06-03
This article addresses practical laboratory challenges in Wnt pathway research and highlights how LGK-974 (Porcupine Inhibitor, SKU B2307) delivers reproducible, nanomolar-precision inhibition of PORCN. Using scenario-driven Q&A, we guide researchers on optimizing protocols, data interpretation, and reliable sourcing for cell-based and translational assays.
-
Tioconazole in Antifungal Innovation: Mechanisms and Transla
2026-06-03
This thought-leadership article explores the mechanistic action of Tioconazole as an antifungal medication, its role in antifungal drug development, and its translational potential. Integrating recent advances in the understanding of ergosterol biosynthesis inhibition and cytochrome P450 targeting, the article provides strategic guidance for researchers, highlights validated workflows, and contextualizes APExBIO’s Tioconazole against the evolving demands of fungal infection models and antifungal resistance research.
-
hiPSC-Derived Intestinal Organoids in Pharmacokinetic Studie
2026-06-02
This study introduces a streamlined protocol for generating human pluripotent stem cell-derived intestinal organoids (IOs), offering a more physiologically relevant in vitro platform for pharmacokinetic research. The protocol enables the long-term expansion and differentiation of IOs into mature intestinal epithelial cells, addressing key limitations of animal models and traditional cell lines.
-
BRCA2 Modulates PARP1 Retention and RAD51 Filament Stability
2026-06-02
This study elucidates a previously unrecognized function of BRCA2 in safeguarding RAD51 filaments from destabilization caused by PARP inhibitor-induced PARP1 retention at DNA repair sites. These mechanistic insights refine our understanding of homologous recombination deficiencies and inform the use of selective PARP inhibitors, such as Talazoparib, in targeting DNA repair-deficient cancers.
-
Protein A/G Magnetic Beads: Technical Workflow Guidance
2026-06-01
Protein A/G Magnetic Beads (SKU K1305) address the need for efficient, low-background purification of IgG antibodies and protein complexes from complex biological samples. These beads are ideal for immunoprecipitation, co-IP, and chromatin IP workflows requiring high specificity, but are not suitable for diagnostic or medical applications.
-
Atrial Natriuretic Peptide (ANP), rat: Translational Assay D
2026-06-01
Explore the advanced translational applications of Atrial Natriuretic Peptide (ANP) peptide hormone in cardiovascular research. This article delivers unique insights into ANP’s mechanistic role, protocol optimization, and cross-domain assay considerations, setting a new benchmark for scientific rigor.
-
Poly(I:C): Advancing Innate Immunity and Dendritic Cell Matu
2026-05-31
Explore the scientific foundations and advanced applications of Poly(I:C), a synthetic double-stranded RNA analog, in stimulating innate immunity and driving dendritic cell maturation. This article uniquely connects epigenetic insights to practical assay design, offering deeper context beyond typical protocol guides.